Codexis Stock Price, News & Analysis (NASDAQ:CDXS)

$7.55 -0.10 (-1.31 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$7.55
Today's Range$7.35 - $7.75
52-Week Range$3.60 - $7.95
Volume353,511 shs
Average Volume174,089 shs
Market Capitalization$372.27 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.58

About Codexis (NASDAQ:CDXS)

Codexis logoCodexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers to evolve and optimize biocatalysts to perform specific and desired chemical reactions at commercial scale. The Company's pharmaceutical products include enzymes, pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and Codex Biocatalyst Panels and Kits. The fine chemicals market consists of several market verticals, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The Company also uses its technology to develop an early stage, enzyme therapeutic product candidate for the treatment of phenylketonuria (PKU) in humans through oral administration.

Receive CDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryBiotechnology
SectorIndustrial Products
SymbolNASDAQ:CDXS
CUSIP19200510
Phone650-421-8100

Debt

Debt-to-Equity RatioN/A
Current Ratio2.05%
Quick Ratio2.00%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$48.84 million
Price / Sales7.47
Cash FlowN/A
Price / CashN/A
Book Value$0.46 per share
Price / Book16.41

Profitability

Trailing EPS($0.65)
Net Income$-8,550,000.00
Net Margins-76.37%
Return on Equity-140.02%
Return on Assets-73.00%

Miscellaneous

Employees106
Outstanding Shares48,350,000

Codexis (NASDAQ:CDXS) Frequently Asked Questions

What is Codexis' stock symbol?

Codexis trades on the NASDAQ under the ticker symbol "CDXS."

How were Codexis' earnings last quarter?

Codexis, Inc. (NASDAQ:CDXS) issued its quarterly earnings results on Tuesday, August, 9th. The biotechnology company reported $0.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.03 by $0.09. The biotechnology company had revenue of $16 million for the quarter, compared to analyst estimates of $15.10 million. Codexis had a negative return on equity of 140.02% and a negative net margin of 76.37%. The company's revenue for the quarter was up 166.7% compared to the same quarter last year. During the same quarter last year, the company posted ($0.14) EPS. View Codexis' Earnings History.

When will Codexis make its next earnings announcement?

Codexis is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Codexis.

Where is Codexis' stock going? Where will Codexis' stock price be in 2017?

4 brokerages have issued 1 year target prices for Codexis' stock. Their forecasts range from $5.50 to $11.00. On average, they anticipate Codexis' stock price to reach $7.81 in the next year. View Analyst Ratings for Codexis.

Who are some of Codexis' key competitors?

Who are Codexis' key executives?

Codexis' management team includes the folowing people:

  • Bernard J. Kelley, Chairman of the Board (Age 73)
  • John J. Nicols, President, Chief Executive Officer, Director (Age 51)
  • Gordon T. Sangster, Chief Financial Officer, Senior Vice President (Age 61)
  • Douglas T. Sheehy J.D., Executive Vice President, Chief Administrative Officer, General Counsel, Secretary (Age 50)
  • Michael Douglas Arthur Aldridge, Senior Vice President - Corporate & Strategic Development
  • James Lalonde, Senior Vice President, Research & Development (Age 54)
  • Thomas R. Baruch J.D., Chairman Emeritus
  • Pam P. Cheng, Director (Age 45)
  • Kathleen Sereda Glaub, Director
  • Patrick Y. Yang, Director (Age 69)

Who owns Codexis stock?

Codexis' stock is owned by a number of of retail and institutional investors. Top institutional investors include VIVO VENTURES VII, LLC (6.30%), Telemark Asset Management LLC (4.24%), Baillie Gifford & Co. (3.06%), Cortina Asset Management LLC (2.16%), Wells Fargo & Company MN (0.81%) and Royce & Associates LP (0.34%). Company insiders that own Codexis stock include Bernard J Kelley, Dennis P Wolf, Patrick Y Yang, Ventures Fund Vii LP Vivo, Ventures Vii Affiliates F Vivo and Vivo Ventures Vii, Llc. View Institutional Ownership Trends for Codexis.

Who sold Codexis stock? Who is selling Codexis stock?

Codexis' stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC and Strs Ohio. View Insider Buying and Selling for Codexis.

Who bought Codexis stock? Who is buying Codexis stock?

Codexis' stock was acquired by a variety of institutional investors in the last quarter, including Telemark Asset Management LLC, Wells Fargo & Company MN, Royce & Associates LP and Baillie Gifford & Co.. View Insider Buying and Selling for Codexis.

How do I buy Codexis stock?

Shares of Codexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Codexis' stock price today?

One share of Codexis stock can currently be purchased for approximately $7.55.

How big of a company is Codexis?

Codexis has a market capitalization of $372.27 million and generates $48.84 million in revenue each year. The biotechnology company earns $-8,550,000.00 in net income (profit) each year or ($0.65) on an earnings per share basis. Codexis employs 106 workers across the globe.

How can I contact Codexis?

Codexis' mailing address is 200 PENOBSCOT DRIVE, REDWOOD CITY CA, 94063. The biotechnology company can be reached via phone at 650-421-8100 or via email at [email protected]


MarketBeat Community Rating for Codexis (CDXS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  268
MarketBeat's community ratings are surveys of what our community members think about Codexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Codexis (NASDAQ:CDXS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.752.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.81$7.81$6.94$6.94
Price Target Upside: 33.55% upside0.48% downside29.67% upside61.34% upside

Codexis (NASDAQ:CDXS) Consensus Price Target History

Price Target History for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ:CDXS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/21/2017HC WainwrightReiterated RatingBuy$8.50N/AView Rating Details
10/13/2017Jefferies GroupBoost Price TargetBuy$9.00 -> $11.00N/AView Rating Details
1/26/2017First AnalysisDowngradeOverweight -> Equal Weight$5.50N/AView Rating Details
1/4/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$6.25N/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Codexis (NASDAQ:CDXS) Earnings History and Estimates Chart

Earnings by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ CDXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018$0.06N/AView Earnings Details
8/9/2017Q2 2017($0.13)($0.13)$9.61 million$10.30 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.15)($0.18)$9.23 million$7.97 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.11)($0.12)$9.15 million$10.00 millionViewListenView Earnings Details
11/8/2016Q3($0.14)$0.06$7.41 million$14.90 millionViewListenView Earnings Details
8/9/2016Q216$0.03$0.12$15.10 million$16.00 millionViewListenView Earnings Details
5/9/2016Q1($0.15)($0.11)$7.49 million$8.00 millionViewListenView Earnings Details
3/3/2016Q4($0.04)$0.02$11.63 million$11.60 millionViewN/AView Earnings Details
11/4/2015Q315($0.11)$0.13$8.85 million$17.40 millionViewListenView Earnings Details
8/11/2015Q215($0.14)($0.14)$7.34 million$6.02 millionViewListenView Earnings Details
5/7/2015Q115($0.12)($0.14)$8.00 million$6.80 millionViewListenView Earnings Details
3/3/2015Q414$0.01$0.07$13.30 million$14.20 millionViewListenView Earnings Details
11/4/2014Q314($0.06)($0.05)$9.00 million$7.47 millionViewListenView Earnings Details
8/6/2014Q214($0.15)($0.22)$8.50 million$6.60 millionViewListenView Earnings Details
5/7/2014Q114($0.10)($0.17)$10.00 million$7.10 millionViewListenView Earnings Details
3/11/2014Q413($0.21)($0.26)$10.00 million$9.50 millionViewListenView Earnings Details
11/12/2013Q313($0.31)($0.24)$8.50 million$3.90 millionViewListenView Earnings Details
8/9/2013Q2 2013($0.28)($0.33)$9.00 million$6.97 millionViewListenView Earnings Details
5/7/2013Q1 2013($0.36)($0.25)$7.63 million$11.48 millionViewListenView Earnings Details
2/27/2013Q4 2012($0.34)($0.41)$9.33 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.15)($0.06)$25.88 million$26.34 millionViewN/AView Earnings Details
8/9/2012($0.18)($0.15)ViewN/AView Earnings Details
5/10/2012($0.15)($0.21)ViewN/AView Earnings Details
2/7/2012($0.11)($0.15)ViewN/AView Earnings Details
11/1/2011($0.08)($0.08)ViewN/AView Earnings Details
7/28/2011($0.10)($0.14)ViewN/AView Earnings Details
5/5/2011($0.07)($0.10)ViewN/AView Earnings Details
2/3/2011($0.06)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Codexis (NASDAQ:CDXS) Earnings Estimates

2017 EPS Consensus Estimate: ($0.35)
2018 EPS Consensus Estimate: ($0.13)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.10)($0.10)($0.10)
Q2 20172($0.14)($0.12)($0.13)
Q3 20172($0.17)($0.14)($0.16)
Q4 20171$0.04$0.04$0.04
Q1 20181($0.13)($0.13)($0.13)
Q2 20181($0.13)($0.13)($0.13)
Q3 20181($0.07)($0.07)($0.07)
Q4 20181$0.20$0.20$0.20
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Codexis (NASDAQ:CDXS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Codexis (NASDAQ CDXS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.80%
Institutional Ownership Percentage: 65.71%
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)
Insider Trades by Quarter for Codexis (NASDAQ:CDXS)

Codexis (NASDAQ CDXS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2017Ventures Vii Affiliates F VivoMajor ShareholderSell1,060,000$5.78$6,126,800.00View SEC Filing  
8/21/2017Patrick Y YangDirectorBuy10,000$3.98$39,800.00View SEC Filing  
11/15/2016Patrick Y YangDirectorBuy10,000$4.83$48,300.00View SEC Filing  
9/8/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell111,600$4.25$474,300.00View SEC Filing  
8/29/2016Dennis P WolfDirectorSell18,000$4.22$75,960.00View SEC Filing  
8/24/2016Bernard J KelleyDirectorSell12,643$4.26$53,859.18View SEC Filing  
8/16/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell86,894$4.25$369,299.50View SEC Filing  
8/15/2016Vivo Ventures Vii, LlcMajor ShareholderSell50,000$4.27$213,500.00View SEC Filing  
8/4/2016Ventures Fund Vii L.P. VivoMajor ShareholderSell80,000$4.22$337,600.00View SEC Filing  
11/11/2015James LalondeSVPSell9,441$3.52$33,232.32View SEC Filing  
9/11/2015Patrick Y YangDirectorBuy10,000$3.47$34,700.00View SEC Filing  
9/10/2015Bernard J. KelleyDirectorSell5,200$3.45$17,940.00View SEC Filing  
8/24/2015Patrick Y YangDirectorBuy10,000$3.84$38,400.00View SEC Filing  
8/14/2015Patrick Y YangDirectorBuy20,000$3.97$79,400.00View SEC Filing  
6/15/2015Dennis P WolfDirectorSell35,416$4.10$145,205.60View SEC Filing  
11/18/2014Patrick Y YangDirectorBuy20,000$2.35$47,000.00View SEC Filing  
11/17/2014Patrick Y YangDirectorBuy20,000$2.34$46,800.00View SEC Filing  
8/12/2014Patrick Y YangDirectorBuy60,000$2.22$133,200.00View SEC Filing  
3/8/2013John J NicolsCEOBuy27,000$2.42$65,340.00View SEC Filing  
3/7/2013John J NicolsCEOBuy54,000$2.22$119,880.00View SEC Filing  
3/4/2013David D O'tooleCFOBuy10,000$2.02$20,200.00View SEC Filing  
11/12/2012David D O'tooleCFOBuy5,000$2.20$11,000.00View SEC Filing  
9/14/2012David D O'tooleCFOBuy5,000$2.78$13,900.00View SEC Filing  
9/14/2012Douglas T SheehySVPSell3,800$2.76$10,488.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Codexis (NASDAQ CDXS) News Headlines

Source:
DateHeadline
$22.66 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter$22.66 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - December 13 at 5:42 AM
Codexis, Inc. – Value Analysis (NASDAQ:CDXS) : December 12, 2017Codexis, Inc. – Value Analysis (NASDAQ:CDXS) : December 12, 2017
finance.yahoo.com - December 12 at 5:07 PM
Codexis, Inc. (CDXS) Expected to Post Earnings of $0.06 Per ShareCodexis, Inc. (CDXS) Expected to Post Earnings of $0.06 Per Share
www.americanbankingnews.com - December 11 at 1:34 PM
Codexis, Inc. breached its 50 day moving average in a Bullish Manner : CDXS-US : December 8, 2017Codexis, Inc. breached its 50 day moving average in a Bullish Manner : CDXS-US : December 8, 2017
finance.yahoo.com - December 8 at 10:05 AM
Codexis, Inc. (CDXS) Director Buys $39,800.00 in StockCodexis, Inc. (CDXS) Director Buys $39,800.00 in Stock
www.americanbankingnews.com - December 7 at 11:26 PM
Codexis (CDXS) Raised to "Hold" at BidaskClubCodexis (CDXS) Raised to "Hold" at BidaskClub
www.americanbankingnews.com - December 2 at 2:38 PM
ETFs with exposure to Codexis, Inc. : November 28, 2017ETFs with exposure to Codexis, Inc. : November 28, 2017
finance.yahoo.com - November 28 at 4:44 PM
Analyzing Galectin Therapeutics (GALT) and Codexis (CDXS)Analyzing Galectin Therapeutics (GALT) and Codexis (CDXS)
www.americanbankingnews.com - November 27 at 9:52 PM
Codexis, Inc. (CDXS) Rating Reiterated by HC WainwrightCodexis, Inc. (CDXS) Rating Reiterated by HC Wainwright
www.americanbankingnews.com - November 21 at 1:16 PM
Codexis, Inc. (CDXS) Given Consensus Rating of "Hold" by AnalystsCodexis, Inc. (CDXS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - November 20 at 3:58 AM
Codexis (CDXS) Presents At 8th Annual Craig-Hallum Alpha Select Conference - SlideshowCodexis (CDXS) Presents At 8th Annual Craig-Hallum Alpha Select Conference - Slideshow
seekingalpha.com - November 18 at 4:50 PM
Edited Transcript of CDXS earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of CDXS earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 10:15 AM
Codexis to Present at Two Investment Conferences in NovemberCodexis to Present at Two Investment Conferences in November
finance.yahoo.com - November 9 at 7:52 PM
Codexis, Inc. to Host Earnings CallCodexis, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 7:52 PM
Codexis Reports Financial Results for the Third Quarter of 2017Codexis Reports Financial Results for the Third Quarter of 2017
finance.yahoo.com - November 9 at 7:52 PM
Codexis reports 3Q lossCodexis reports 3Q loss
finance.yahoo.com - November 9 at 7:52 PM
Codexis, Inc. breached its 50 day moving average in a Bullish Manner : CDXS-US : November 6, 2017Codexis, Inc. breached its 50 day moving average in a Bullish Manner : CDXS-US : November 6, 2017
finance.yahoo.com - November 6 at 6:14 PM
Codexis, Inc. (CDXS) Expected to Announce Earnings of -$0.16 Per ShareCodexis, Inc. (CDXS) Expected to Announce Earnings of -$0.16 Per Share
www.americanbankingnews.com - November 4 at 1:20 PM
ETFs with exposure to Codexis, Inc. : November 2, 2017ETFs with exposure to Codexis, Inc. : November 2, 2017
finance.yahoo.com - November 2 at 5:54 PM
Codexis to Hold 2017 Third Quarter Conference Call on November 9Codexis to Hold 2017 Third Quarter Conference Call on November 9
feeds.benzinga.com - November 2 at 7:43 AM
Codexis, Inc. (CDXS) Scheduled to Post Quarterly Earnings on MondayCodexis, Inc. (CDXS) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - October 30 at 8:50 AM
Codexis, Inc. (CDXS) Receives Consensus Rating of "Hold" from AnalystsCodexis, Inc. (CDXS) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 26 at 3:32 AM
1 Small-Cap Biotech Stock to Buy Right Now1 Small-Cap Biotech Stock to Buy Right Now
finance.yahoo.com - October 25 at 6:36 PM
ETFs with exposure to Codexis, Inc. : October 23, 2017ETFs with exposure to Codexis, Inc. : October 23, 2017
finance.yahoo.com - October 23 at 3:49 PM
Codexis, Inc. (CDXS) Expected to Announce Quarterly Sales of $10.00 MillionCodexis, Inc. (CDXS) Expected to Announce Quarterly Sales of $10.00 Million
www.americanbankingnews.com - October 17 at 2:02 AM
Analysts Issue Forecasts for Codexis, Inc.s Q4 2017 Earnings (CDXS)Analysts Issue Forecasts for Codexis, Inc.'s Q4 2017 Earnings (CDXS)
www.americanbankingnews.com - October 16 at 5:18 AM
Codexis, Inc. (CDXS) Price Target Raised to $11.00Codexis, Inc. (CDXS) Price Target Raised to $11.00
www.americanbankingnews.com - October 13 at 7:02 PM
Codexis Reaches Analyst Target PriceCodexis Reaches Analyst Target Price
www.thestreet.com - October 13 at 5:41 PM
HC Wainwright Boosts Codexis, Inc. (CDXS) Price Target to $8.50HC Wainwright Boosts Codexis, Inc. (CDXS) Price Target to $8.50
www.americanbankingnews.com - October 13 at 7:34 AM
Codexis And Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform PartnershipCodexis And Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
www.thestreet.com - October 12 at 10:55 PM
Codexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform PartnershipCodexis and Nestlé Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership
finance.yahoo.com - October 12 at 5:53 PM
ETFs with exposure to Codexis, Inc. : October 12, 2017ETFs with exposure to Codexis, Inc. : October 12, 2017
finance.yahoo.com - October 12 at 5:53 PM
Codexis, Inc. :CDXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 11, 2017Codexis, Inc. :CDXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 11, 2017
finance.yahoo.com - October 11 at 6:34 PM
Codexis, Inc. (CDXS) Upgraded to Hold by Zacks Investment ResearchCodexis, Inc. (CDXS) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - October 11 at 5:56 PM
3 Top Small-Cap Stocks to Buy in October3 Top Small-Cap Stocks to Buy in October
finance.yahoo.com - October 4 at 12:23 PM
Codexis, Inc. (CDXS) Rating Reiterated by Jefferies Group LLCCodexis, Inc. (CDXS) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - October 2 at 3:50 PM
Codexis, Inc. (CDXS) Given Average Rating of "Hold" by AnalystsCodexis, Inc. (CDXS) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 1 at 2:50 AM
Codexis, Inc. (CDXS) Expected to Announce Earnings of -$0.14 Per ShareCodexis, Inc. (CDXS) Expected to Announce Earnings of -$0.14 Per Share
www.americanbankingnews.com - September 27 at 6:20 AM
Codexis (CDXS) & Bio-Techne Corp (TECH) Head to Head AnalysisCodexis (CDXS) & Bio-Techne Corp (TECH) Head to Head Analysis
www.americanbankingnews.com - September 20 at 2:22 PM
Codexis, Inc. (CDXS) Major Shareholder Ventures Vii Affiliates F. Vivo Sells 1,060,000 SharesCodexis, Inc. (CDXS) Major Shareholder Ventures Vii Affiliates F. Vivo Sells 1,060,000 Shares
www.americanbankingnews.com - September 18 at 10:26 PM
Comparing Codexis (CDXS) and Its RivalsComparing Codexis (CDXS) and Its Rivals
www.americanbankingnews.com - September 17 at 10:32 PM
$10.00 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter$10.00 Million in Sales Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - September 10 at 5:40 AM
Codexis (CDXS) Presents At 24th Annual NewsMakers In The Biotech Industry - SlideshowCodexis (CDXS) Presents At 24th Annual NewsMakers In The Biotech Industry - Slideshow
seekingalpha.com - September 9 at 9:44 PM
-$0.14 Earnings Per Share Expected for Codexis, Inc. (CDXS) This Quarter-$0.14 Earnings Per Share Expected for Codexis, Inc. (CDXS) This Quarter
www.americanbankingnews.com - September 8 at 2:20 PM
Codexis, Inc. (CDXS) Given Consensus Rating of "Hold" by BrokeragesCodexis, Inc. (CDXS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - September 6 at 2:28 AM
Codexis to Present at Four Investment Conferences in SeptemberCodexis to Present at Four Investment Conferences in September
finance.yahoo.com - August 31 at 4:58 PM
3 Stocks Set to Pop3 Stocks Set to Pop
www.fool.com - August 16 at 2:24 PM
Financial Comparison: Codexis (NASDAQ:CDXS) & Repros Therapeutics (RPRX)Financial Comparison: Codexis (NASDAQ:CDXS) & Repros Therapeutics (RPRX)
www.americanbankingnews.com - August 14 at 8:06 PM
Q3 2017 EPS Estimates for Codexis, Inc. (NASDAQ:CDXS) Lowered by Jefferies GroupQ3 2017 EPS Estimates for Codexis, Inc. (NASDAQ:CDXS) Lowered by Jefferies Group
www.americanbankingnews.com - August 14 at 3:34 AM
HC Wainwright Analysts Give Codexis, Inc. (NASDAQ:CDXS) a $8.00 Price TargetHC Wainwright Analysts Give Codexis, Inc. (NASDAQ:CDXS) a $8.00 Price Target
www.americanbankingnews.com - August 13 at 3:32 PM

SEC Filings

Codexis (NASDAQ:CDXS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Codexis (NASDAQ:CDXS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Codexis (NASDAQ CDXS) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.